GEHC in the 13F filings
Ge Healthcare Technologies I · CUSIP 36266G107
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 14 Aug 2025
- latest of these filings; the earliest 8 Aug 2025
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 15 listed it in both
- Shares listed
- 97,344,593
- combined, among listed positions
- Reported value
- $7.2bn
- combined, at the quarter end
Among the 95 comparable managers: 15 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GEHC in Q2 2025
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Dodge & Coxexisting position · 23,567,950 shares now+6,982,441
- Harris Associates LPexisting position · 9,672,433 shares now+4,038,491
- Holocene Advisors LPexisting position · 4,027,352 shares now+2,581,522
- Citadel Advisors LLCexisting position · 9,299,929 shares now+2,383,389
- Millennium Management LLCnew position · 2,193,572 shares now+2,193,572
Reductions
- Capital Research Global Investorsexisting position · 19,974,402 shares now-31,220,666
- T. Rowe Price Associates Incexisting position · 2,055,454 shares now-910,880
- AllianceBernstein LPexisting position · 5,172,393 shares now-786,315
- Bridgewater Associates LPexisting position · 15,066 shares now-111,996
- D1 Capital Partners LPexisting position · 1,159,584 shares now-90,000
New positions and exits
New (5)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2022 | 1 | $371m | n.a. | n.a. |
| Q1 2023 | 13 | $8.0bn | n.a. | n.a. |
| Q2 2023 | 21 | $8.7bn | n.a. | n.a. |
| Q3 2023 | 14 | $6.6bn | n.a. | n.a. |
| Q4 2023 | 13 | $7.3bn | 7 | 8 |
| Q1 2024 | 17 | $9.7bn | 10 | 5 |
| Q2 2024 | 17 | $8.0bn | 9 | 5 |
| Q3 2024 | 20 | $10.7bn | 9 | 11 |
| Q4 2024 | 18 | $8.8bn | 10 | 6 |
| Q1 2025 | 18 | $8.4bn | 9 | 11 |
| Q2 2025 | 22 | $7.2bn | 15 | 6 |
| Q3 2025 | 14 | $6.3bn | 6 | 9 |
| Q4 2025 | 13 | $8.1bn | 17 | 22 |
| Q1 2026 | 11 | $6.3bn | 19 | 18 |
| Q2 2026 | 9 | $4.9bn | 24 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEHC and LLY →GEHC and JNJ →GEHC and VRTX →Choose a stock to compare with GEHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEHC, latest filings →Back to the 13F Explorer →